MedTrace Logo

Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients

NCT00672672 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-08-15

No results posted yet for this study

Summary

This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.

Conditions

Interventions

BIOLOGICAL

autologous platelet gel

Patients will receive APG to the surgical site in the operating room. The control site will receive no treatment.

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Ali Khoynezhad, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-13
Primary Completion
2010-01-06
Completion
2010-01-06

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00672672 on ClinicalTrials.gov